Knowledge center
Home Knowledge center Industry Info Bio Tech Parks

Bio Tech Parks

There 27 biotech parks across India. The largest are located in Hyderabad and in Pune. Important biotech parks are located also in Lucknow and Chennai. Typically, biotech parks are meant to provide the following facilities and services:

  • Research,
  • Incubation,
  • Clustering of private industries.

Indian Biotech companies are earning huge profits and are using these profits for further investments considering the overall promising market scenario, e.g.

 

  • Wockhardt acquired Pinewood Laboratories.
  • Reliance Life Sciences took staked control of GeneMedix Plc.
  • Cipla has invested in its biotech ventures with smaller companies overseas.
  • Dr. Reddy's Lab primarily a strong player in chemical research has moved in the biotech research.
  • Biocon Limited reported better-than-expected net profit for the quarter ended March 2012.
Leading Biotechnology Companies in India:
  • Biocon
  • Serum Institute of India
  • Panacea Biotec
  • Reliance Life Sciences
  • Syngene International
  • Bharat Biotech
  • Indian Immunologicals
Growth Drivers in the Biotech Sector:
  • Public Private Partnership (PPP) route to innovation.
  • Upgrading facilities and capabilities to global standards, for better access to partnership
  • Direct investments from international biotech firms.
  • Collaborations and alliances in Biotech Education and Research & Development.
  • Increasing government support.
  • Strengthening confidentiality and IP protection.
Opportunities:
  • Large domestic market and huge export potential
  • Low cost research base for international companies in comparison with other countries
  • Vast and diverse disease based patient populations provide unique opportunities for clinical research and clinical trials
  • Supportive Government policy on embryonic stem cells research provides a useful opportunity for International companies to pursue such research in India
  • Plant & microbial bio-diversity provides vast prospecting opportunities for new drugs
  • Conducive Government policy on GM crops provides useful opportunities for Agri-biotech companies
Challenges:
  • Lack of public private partnership.
  • Risk averse nature of industry.
  • Necessary international funding required for Indian companies to be able to invest in cutting edge research.
  • Streamlining India’s regulatory framework to meet global standards.
  • The Indian market being price sensitive, the industry is still learning to be cost effective.
  • Partnership with pharmaceutical industry.
Key Trade Show: India bio 2012

Annual event organized by Department of Information Technology, Biotechnology and Science & Technology, Government of Karnataka, Vision Group on Biotechnology and MM Activ Sci-Tech Communications with support from ABLE (Association of Biotechnology Led Enterprise.)

Back